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Abstract: Understanding the mechanism of nanosilver-dependent antibacterial activity against 
microorganisms helps optimize the design and usage of the related nanomaterials. In this study, 
we prepared four kinds of 10 nm-sized silver nanoparticles (AgNPs) with dictated surface 
chemistry by capping different ligands, including citrate, mercaptopropionic acid, mercapto-
hexanoic acid, and mercaptopropionic sulfonic acid. Their surface-dependent chemistry and 
antibacterial activities were investigated. Owing to the weak bond to surface Ag, short carbon 
chain, and low silver ion attraction, citrate-coated AgNPs caused the highest silver ion release 
and the strongest antibacterial activity against Escherichia coli, when compared to the other 
tested AgNPs. The study on the underlying antibacterial mechanisms indicated that cellular 
membrane uptake of Ag, NAD+/NADH ratio increase, and intracellular reactive oxygen species 
(ROS) generation were significantly induced in both AgNP and silver ion exposure groups. 
The released silver ions from AgNPs inside cells through a Trojan-horse-type mechanism were 
suggested to interact with respiratory chain proteins on the membrane, interrupt intracellular O
2
 
reduction, and induce ROS production. The further oxidative damages of lipid peroxidation and 
membrane breakdown caused the lethal effect on E. coli. Altogether, this study demonstrated 
that AgNPs exerted antibacterial activity through the release of silver ions and the subsequent 
induction of intracellular ROS generation by interacting with the cell membrane. The findings 
are helpful in guiding the controllable synthesis through the regulation of surface coating for 
medical care purpose.
Keywords: silver nanoparticles, surface chemistry, silver ion release, Trojan-horse-type 
mechanism, respiratory chain, oxidative stress
Introduction
Due to the excellent antimicrobial effects of nanosilver against a wide range of 
microbes, such as bacteria, fungi, and even some viruses, this kind of nanomaterial 
is becoming more and more popular.1 Its disinfection efficiency has been widely 
explored in diverse aspects, including water treatment, medical care, and food packages. 
Since 2013, nanosilver-related commercial products have expanded to .400 types 
and occupied more than one-half of the nanotechnology-based consumer product 
amounts,2 revealing the increasing demands and promising commercial values in the 
production of nanosilver.
Currently available studies have indicated that nanosilver with different 
characteristics may exert distinct antibacterial capabilities against diverse micro-
organisms. For example, the minimum inhibitory concentrations (MICs) of silver 
nanoparticles (AgNPs, 13.4 nm) were 6.6 and 33 nM for Escherichia coli and 
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Staphylococcus aureus, respectively.3 Another study 
indicated that the effective growth inhibition concentrations 
of myramisin-capped AgNPs with the particle size of 10 nm 
were 2.5 and 5 μM for these two bacteria, respectively.4 As 
for the commercial silver nanopowder, the colony forming 
units (CFU) of E. coli were completely inhibited when the 
exposure concentration was 300 μg/mL.5 Apparently, the fac-
tors, including particle size, surface capper, and the particle 
shape, greatly influenced the antibacterial abilities of nano-
silver. On-purpose design for the time- and dose-controllable 
formula of AgNPs has been an important subject regarding 
the optimization of their antibacterial properties in related 
commercial products.
The surface ligand-dependent chemistry and potential 
biological effects have been widely discussed for diverse 
nanomaterials, including AgNPs.6–8 Under ambient condi-
tion, O
2
 molecule would chemisorb on AgNPs and oxidize 
the surface Ag atom into monovalent ion of Ag+. It is sup-
posed to be one of the key reactions contributing to the 
antibacterial activity of AgNPs.1,9–12 Controlled release of 
biologically active silver from nanosilver can be regulated 
by the surface ligands. Due to the relatively higher silver 
ion release ratio, citrate-capped AgNPs significantly 
enhanced the antibacterial zone of E. coli, when compared 
to 11-mercaptoundecanoic acid-capped AgNPs based 
on the Kirby-Bauer disk susceptibility test.12 In contrast, 
the dissolution rate and the amount of silver ions from 
polyvinylpyrrolidone-stabilized AgNPs were higher than 
those from citrate-stabilized AgNPs, because citrate coating 
was relatively more efficient in preventing silver ions from 
releasing.13 Branched polyethylenimine-capped AgNPs with 
positive charges tended to adsorb more on the membrane of 
gram-positive bacteria than did neutral polyvinylpyrrolidone-
coated AgNPs and negatively charged citrate-coated AgNPs, 
thus causing more effective sterilization.14 Accordingly, the 
modification of AgNPs with surface ligands based on the 
adjustment of their coordination atom, carbon chain length, 
or the terminal group is very promising in regulating the 
antibacterial activities of AgNPs.
Understanding the antibacterial mechanisms of AgNPs is 
helpful in guiding the rational design and synthesis of ideal 
products, as this still remains ambiguous. O
2
 molecules may 
chemically adsorb on the 111 facet of AgNP surface and 
then be incompletely reduced to reactive oxygen species 
(ROS, ⋅OH, O
2
-⋅). The biologically active radical species 
are capable of attacking the cell membrane, posing oxidative 
stress, or even causing death to the cells.15–17 Meanwhile, 
the released silver ions can approach negatively charged 
cell membrane and interfere with its integrity.1 Moreover, 
the internalized AgNPs through endocytosis or pinocytosis 
may pose a Trojan-horse-type effect, releasing silver ions in 
the cytoplasm through the reactions with organelles such as 
mitochondria.1 The intracellular silver ions can directly bind 
with the thiol-containing enzymes, such as respiratory chain 
complex I, causing the interruption of electron transfer and 
ROS production that induces oxidative stress and lesions to 
cells.18,19 Thus, whether the extracellular ROS generated from 
AgNP surface or interrupted cellular machinery induced by a 
Trojan-horse-type effect leads to the intracellular hazardous 
effects still remains an open question.
Previous studies on surface-coating effect of AgNPs were 
based on the commercially available AgNPs,3 which might 
limit the rational comparison of AgNP effects mediated by 
the different ligand structural factors. In this study, four 
types of 10 nm-sized AgNPs with different organic ligands, 
including citrate (Cit), mercaptopropionic acid (MPA), 
mercaptohexanoic acid (MHA), and mercaptopropionic 
sulfonic acid (MPS), were intentionally prepared, with regard 
to the structural factors of coordination atom, carbon chain 
length, and terminal group. Using E. coli in 2 mM NaHCO
3
 
as the experimental model, the ligand-dependent chemistry 
and the antibacterial activity of AgNPs were evaluated. The 
results indicated that the tested nanosilver exerted antibacterial 
activities in both time- and concentration-dependent manners. 
The capabilities of nanosilver in inhibiting bacteria were 
ascribed to the surface ligand-mediated silver ion release 
from both extracellular process and intracellular manner 
through a Trojan-horse-type effect. The studies using Cit@
AgNPs showed that internalized AgNPs caused cell damage 
through binding with the respiratory chain-related proteins 
and interrupting the electron transfer process. The findings 
herein have provided a promising strategy for the intended 
construction of nanosilver by surface chemistry regulation 
on the basis of understanding its underlying antibacterial 
mechanism.
Materials and methods
The synthesis and characterization 
of agNPs
The Cit@AgNPs was synthesized according to the previously 
reported method.20 In brief, 5 mM sodium citrate (Sinopharm) 
and 25 μM tannic acid (Sigma-Aldrich) were added into the 
250 μM AgNO
3
 (Sinopharm) solution. The mixture was 
continuously stirred and refluxed until the solution turned 
to light yellow. Cit@AgNPs was purified by ultrafiltration 
(10 kDa cutoff; Millipore) and washed twice with deionized 
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water. The suspension (40 μg/mL) was stored at 4°C in 
darkness until use.
The other three kinds of nanoparticles, including MPA@
AgNPs, MHA@AgNPs, and MPS@AgNPs, were synthesized 
by ligand exchange, which included mixing and overnight 
stirring 20 μg/mL Cit@AgNPs (6.0 nM) and the respective 
ligand molecules of 264 μg/mL MPA, 64 μg/mL MHA, and 
108 μg/mL MPS (Alfa-Aesar) in 10 mM phosphate-buffered 
saline (PBS) (pH 7.4) at ambient temperature. The concentra-
tions of the ligands were selected based on the optimization of 
ligand/AgNP molar ratio in preliminary studies, ie, the molar 
ratios of MPA, MHA, and MPS to AgNPs were 50,000:1, 
500,000:1, and 10,000:1, respectively. The unreacted reagents 
were removed by ultrafiltration, and the products were further 
washed with deionized water twice to obtain the MPA@
AgNPs, MHA@AgNPs, and MPS@AgNPs. The prepared 
NP suspensions were kept at 4°C in darkness.
The morphologies of AgNPs were observed with trans-
mission electron microscopy (TEM, 2100f; JEOL). The mea-
surements, including X-ray photoelectron-binding energy 
analysis (AXIS UltraDLD; Kratos), UV–vis absorption 
(DU-800; Beckman), hydrodynamic size, and zeta potential 
(Mastersizer 2000; Malvern), were conducted to characterize 
the surface modification of these four kinds of AgNPs.
As for the determination of silver ion release, the as-
prepared four AgNPs were resuspended in the exposure 
medium of 2 mM NaHCO
3
 (Sinopharm) at the concentrations 
of 1, 5, and 15 μg/mL, respectively, and incubated at 37°C 
under shaking (220 rpm) for 6 and 24 h. The filtrates obtained 
by ultrafiltration with 3 kDa cutoff membrane (Millipore) 
were used for the quantification of silver ion release. After suf-
ficient digestion of filtrates by acid mixture (65% HNO
3
:30% 
H
2
O
2
, 1:1; Sinopharm), inductively coupled plasma mass 
spectrometry (ICP-MS, Agilent 8800) was utilized to quantify 
the released silver ions from AgNP suspension.
agNP exposure to E. coli
One colony of E. coli (MG 1655) was inoculated into 
liquid Luria–Bertani (LB; Sigma-Aldrich) medium and 
grew at 37°C under shaking. The aliquots of suspension 
(200 μL) were collected at intervals of 30 or 60 min for the 
determination of the optical density at 600 nm (OD
600
) using 
UV–vis spectrophotometer (DU-800; Beckman) to plot the 
growth curve of E. coli. The exponential growth phase of 
E. coli was reached after 3 h culture in LB growth medium, 
according to the growth curve (Figure S1). Therefore, E. coli 
entering into this rapid growth period was used for the expo-
sure experiments.
The exposure of E. coli was conducted according to the 
previously reported protocol.21 After 3 h incubation, E. coli 
was centrifuged, washed, and resuspended in 2 mM NaHCO
3
 
at the concentration of 107 cfu/mL. The exposure groups 
included AgNPs (1, 5, and 15 μg/mL) and AgNO
3
 (5, 20, 
50, 200, and 1,000 ng/mL). The treatment was performed 
on a shaker at 37°C with the rotary speed of 220 rpm. After 
6 h exposure, the mixture was centrifuged at 1,000× g for 
5 min. The precipitate was washed with NaHCO
3
 medium. 
The pellet of E. coli was resuspended in 100 μL of LB cul-
ture medium and transferred to the transparent 96-well plate. 
The treated E. coli grew in the incubator (KS 4000i control, 
IKA®, Staufen, Germany) overnight at 37°C under the rotary 
speed of 220 rpm. The values of OD
600
 were determined to 
evaluate the viabilities of E. coli upon diverse stimuli.
The additional exposure groups were also designed to 
investigate the antagonistic effects of glutathione (GSH) 
(Sigma-Aldrich) and Na
2
S
2
O
3
 (Sinopharm) on AgNPs and 
silver ions, respectively. More specifically, E. coli was 
stimulated with AgNPs (1, 5, and 15 μg/mL) or AgNO
3
 
(5, 20, 50, 200, and 1,000 ng/mL) in the presence of 1 mM 
GSH or 0.1 mM Na
2
S
2
O
3
 for 6 h, respectively. The bacterial 
viability in each group was evaluated as described earlier. 
Regarding the antagonistic effects of these two chemicals 
in toxicological studies, four exposure groups including 
15 μg/mL Cit@AgNPs, 15 μg/mL Cit@AgNPs plus 1 mM 
GSH, 15 μg/mL Cit@AgNPs plus 0.1 mM Na
2
S
2
O
3
, and 
0.5 μg/mL AgNO
3
 were set up, and E. coli in each group was 
stimulated for 6 h. After the exposure was terminated, the 
bacterial samples were washed with PBS and submitted to the 
subsequent pretreatments for the morphological observation, 
silver uptake evaluation, NAD+/NADH ratio test, malonyl-
dialdehyde (MDA), and 8-oxoguanine assays.
Morphological observation of E. coli
After the exposure, E. coli from each group was resuspended 
in 2.5% glutaraldehyde/PBS (SP1-CHEM). The fixation 
was processed overnight at 4°C. The dehydration was suc-
cessively performed using 30, 50, 70, 80, 90, 95, and 100% 
ethanol (Sinopharm). Isobutyl acetate (Sinopharm) was used 
to replace ethanol for scanning electronic microscope (SEM, 
SU8020; Hitachi) observation.
ag uptake and distribution by E. coli
E. coli samples from the control, 15 μg/mL Cit@AgNP, and 
0.5 μg/mL AgNO
3
 exposure groups were submitted to the 
digestion with 2 mL of acidic mixture (65% HNO
3
:30% H
2
O
2
, 
1:1; Sinopharm) for the determination of total Ag uptake. 
International Journal of Nanomedicine 2017:12submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3196
long et al
The equivalent E. coli samples from exposure groups were 
lysed via intermittent sonication on ice for 1 min. The samples 
were subsequently centrifuged at 30,000× g for 30 min. The 
supernatant and precipitate were separately collected and 
digested to obtain the membrane and cytoplasm fractions of 
E. coli. Silver concentrations in both fractions were quantita-
tively measured with ICP-MS for Ag distribution in E. coli.
NaD+/NaDh ratio test
The assay of NAD+/NADH ratio was used to evaluate the 
disturbance of AgNPs on the respiration chain in E. coli. The 
exposed samples were treated with 0.2 M NaOH and 0.2 M 
HCl (Sinopharm) at 100°C for 10 min to extract NADH and 
NAD+, respectively. After 5 min centrifugation, the superna-
tant samples were collected and analyzed using the NAD+/
NADH Assay Kit (ab65348; Abcam).
Intracellular rOs assay
E. coli were exposed using the similar protocol to other 
assays, such as morphological observation and NAD+/NADH 
ratio. After the exposure was terminated, E. coli in each group 
was incubated with ROS probe of 10 μM 2,7-dichlorodi-
hydrofluorescein diacetate (DCFH-DA) (Sigma-Aldrich) 
at 37°C for 30 min. After removing the redundant probes 
outside cells, the fluorescent signal (λ
ex
/λ
em
 =484/525 nm) 
was measured with the microplate reader (Varioskan® Flash; 
Thermo Fisher Scientific, Waltham, MA, USA) to evaluate 
the intracellular ROS production in the exposed E. coli.
MDa generation in E. coli
The content of MDA in AgNP-exposed E. coli was quanti-
fied by the lipid peroxidation assay kit (Abcam). Briefly, 
the bacteria were harvested and washed with cold PBS 
after exposure. Then, the cells were homogenized in MDA 
lysis buffer and centrifuged at 13,000× g for 10 min. The 
supernatant was collected for MDA measurement. MDA in 
samples reacted with thiobarbituric acid (TBA) and formed 
adducts with red color. The level of MDA production in 
each exposure group was quantified according to the specific 
absorbance of adducts at 532 nm.22
8-Oxoguanine determination using liquid 
chromatography-mass spectrometry/mass 
spectrometry (lc-Ms/Ms)
The oxidative stress can induce DNA damage, resulting in the 
formation of 8-oxoguanine (8-oxo-dG). After the stimulation, 
E. coli sample from each group was extracted and processed 
for enzymatic hydrolysis using Bacterial DNA Kit (Omega). 
The levels of 8-oxo-dG were measured with LC-MS/MS 
using the pair ions of m/z 284/168 as the quantitative ions. 
The detection limit of the analytical method was 2 nM.
statistical analysis
All the data were acquired from three independent experi-
ments, and the values were expressed as average ± standard 
deviation. The statistical analysis was performed using 
Student’s t-test. The significant difference was demonstrated 
by P,0.05.
Results and discussion
characterization of agNPs
AgNPs with particle size not more than 10 nm exhibited 
surface-dependent ion release and toxicity.7 In this study, 
the monodisperse citrate-coated AgNPs of ~10 nm were 
synthesized by chemically reducing silver citrate with trace 
tannic acid according to the previously reported method.20 
The characterization results of the prepared nanoparticles are 
presented in Figure 1. The size distribution of Cit@AgNPs 
based on TEM image is 10.2±2.3 nm. X-ray photoelectron 
spectroscopy (XPS) data in Figure S2 reveal the doublet 
Ag3d peaks at 368.2 and 374.2 eV, demonstrating that Ag 
core of Cit@AgNPs mainly stays at zero valence. C1s spectra 
can be fitted into four peaks with the corresponding bind-
ing energies of C-C, C-O, free O=C-O, and Ag coordinated 
O=C-O of citrate (Figure S2).23,24 Thus, based on electronic 
effect and steric effect, the interface structure as shown in 
the cartoon (Figure 1) was suggested. Citrate ligand capped 
the thermodynamic-stabilized AgNPs through the coordina-
tion of two carboxyl groups to the surface Ag atoms. The 
other free carboxyl group in citrate oriented outward and 
constituted the outer layer of AgNPs, resulting in negative 
surface charges (-47.4 mV) of Cit@AgNPs and high stability 
in aqueous dispersion.
The selection of the other three ligands was based on the 
structural factors including the coordination atom (O or S), 
carbon chain length (3C or 6C), and the terminal group 
(-COO- or -SO
3
-). These factors could control the surface 
Ag atom activity, O
2
 access, and Ag+ release of the synthe-
sized AgNPs. The exchange of the surface citrate with free 
ligands of MPA, MHA, and MPS on silver core produced 
MPA@AgNPs, MHA@AgNPs, and MPS@AgNPs, respec-
tively. Considering the replacing ligands were superfluous 
in the reactions and they had relatively higher binding 
affinities to Ag surface than citrate, these three synthesized 
AgNPs were qualified for the subsequent experiments after 
the ligand exchange equilibrium reached and the complete 
wash of the products with deionized water using 10 kDa 
cutoff ultrafiltration devices. The TEM images showed 
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that they were spherically shaped and monodispersive. 
The respective particle sizes were 10.2±2.5 nm for MPA@
AgNPs, 10.2±2.2 nm for MHA@AgNPs, and 9.9±2.0 nm 
for MPS@AgNPs. The similar particle sizes of the four 
synthesized AgNPs showed that no changes in particle 
aggregation occurred during the surface ligand exchange of 
the nanoparticles. XPS data in Figure S2 indicate that they 
share similar characteristics: 1) AgNPs have a weakened 
resolved peak of Ag coordinated O=C-O and an enhanced 
peak of C-S in C1s spectra, and 2) the doublet electronic-
binding energy for S2p spectra is decreased. This suggested 
that instead of citrate, the ligands of MPA, MHA, and MPS 
anchored to the surface of AgNPs through the coordination 
between thiol groups and Ag atom, thus forming MPA@
AgNPs, MHA@AgNPs, and MPS@AgNPs, respectively.23,24 
In addition, the S2p spectra of MPS@AgNPs showed a 
fitted peak at 167.9 eV assigned to the sulfonic acid group 
of MPS molecule.25 The free carboxyl groups and sulfonic 
acid in outer layers of AgNPs endowed them with the 
negatively charged surfaces, and the zeta potentials in water 
were -34.5 mV for MPA@AgNPs, -29.1 mV for MHA@
AgNPs, and -32.6 mV for MPS@AgNPs. The maximum 
absorbance of surface plasmon resonance (SPR) was in 
the narrow range of 392–396 nm, indicating the dispersion 
systems for these four AgNPs were robust and the particles 
had high monodispersity.
surface ligands regulate silver ion release 
from agNPs in vitro
Until now, the question as to whether the released silver 
ions or ROS mainly explain AgNP-induced antibacterial 
activities has been hotly debated. Herein, silver ion release 
from four as-prepared AgNPs in 2 mM NaHCO
3
 solution was 
determined after 6 and 24 h incubation at 37°C. The results 
shown in Figure 2A and B indicate that ionic silver levels in 
the solutions exhibit both concentration- and time-dependent 
increase. Namely, silver ion release increased with AgNP 
concentrations ranging from 1 to 15 μg/mL. As the incuba-
tion time proceeded from 6 to 24 h, AgNPs released more 
silver ions into the solution. Silver ion release from AgNPs 
could be explained by the in vitro process in which the 
ambient O
2
 contacted and chemosorbed on AgNP surface, 
subsequently oxidized core Ag0 into Ag+ that freely dif-
fused into the surrounding solutions.9 When the effect of 
the surface ligand on silver ion release from AgNPs was 
investigated, it was found that during the monitoring time 
scale (6–24 h), AgNPs in NaHCO
3
 released silver ions in the 
following order: Cit@AgNPs . MPS@AgNPs . MPA@
AgNPs . MHA@AgNPs. For example, at the concentra-
tion of 15 μg/mL, the ionic silver released from AgNPs 
was 68.9 ng/mL for Cit@AgNPs, 35.8 ng/mL for MPS@
AgNPs, 22.1 ng/mL for MPA@AgNPs, and 18.9 ng/mL for 
MHA@AgNPs after 24 h incubation at 37°C. In contrast 
to the other three AgNPs with sulfur atom of the ligands 
binding on the surface, the ligand of citrate anchored to the 
surface of silver core through oxygen atoms with relatively 
weaker binding affinity, facilitating adsorption exchange 
with surrounding O
2
, and further oxidative dissolution of 
Ag0.26,27 The shortest carbon chain of citrate among four 
tested ligands had the weakest capacity for oxygen isola-
tion and caused the highest dissolution of Ag0 via easiest 
exposure access of silver core to environmental O
2
.28 Among 
Figure 1 The cartoon depiction and the physicochemical parameters of four agNPs tested in this study.
Abbreviations: agNPs, silver nanoparticles; cit, citrate; MPa, mercaptopropionic acid; Mha, mercaptohexanoic acid; MPs, mercaptopropionic sulfonic acid; sPr, surface 
plasmon resonance; TeM, transmission electron microscope.
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three AgNPs coated with thiol groups, the terminal group 
of -SO
3
- in the ligand MPS had lower affinity to release Ag+ 
than -COO-, thus causing less dissolved silver ions retaining 
on the particle surface and more ions being liberated to the 
surrounding solution.9 According to the results described 
earlier, the determined silver ion release order for all four 
tested AgNPs was closely dependent on their surface ligands. 
Therefore, the theoretical design through structural ligand 
regulation might specifically control the silver core oxidation 
by ambient O
2
 and the further release of silver ions, which 
could subsequently be involved with their biological effects. 
This also offered a promising approach for uncovering the 
underlying mechanism for AgNP-induced antibacterial 
activities by synthesizing diverse AgNPs with the specific 
characteristics to be tested.
agNPs produce antibacterial activities via 
a Trojan-horse-type mechanism
E. coli can be cultured in simple media, such as NaHCO
3
, 
which has little effect on chemistry and bioavailability of the 
active species produced by nanosilver. Thus, E. coli in 2 mM 
NaHCO
3
 was used as the model organism to study the anti-
bacterial activities and the related mechanism of nanosilver. 
As shown in Figure 3A, when the exposure concentrations 
were controlled at 1, 5, and 15 μg/mL, all four AgNPs 
exhibited an obvious concentration-dependent inhibition on 
E. coli viability after 6 h exposure. Based on the comparison 
of the bacterial viabilities in different treatments (Figure 3A), 
the inhibition efficiency of AgNPs on bacterial growth was 
in the following order: Cit@AgNPs . MPS@AgNPs . 
MPA@AgNPs . MHA@AgNPs, indicating the surface 
coating could obviously mediate the antibacterial activities 
of AgNPs. The surface coating effect that was previously 
reported indicated that citrate-coated AgNPs exerted higher 
toxicities when compared to those coated with biodegradable 
polymer,29 although no differences were observed between 
AgNPs with polyvinylpyrrolidone or oleic acid coatings in 
an earthworm study.30 The antibacterial order observed was 
exactly consistent with the trend of silver ion release from 
these AgNPs (Figure 2). This suggested that the released 
silver ions might mainly contribute to AgNP-induced anti-
bacterial activities.
In order to further clarify the roles of released silver ions, 
the antibacterial activities were further evaluated by adding 
the reductase of GSH or ion ligand of Na
2
S
2
O
3
 in AgNP 
exposure systems. The results in Figure 3B and C show that 
both 1 mM GSH and 0.1 mM Na
2
S
2
O
3
 can efficiently block 
AgNP exposure-dependent toxicity to E. coli, and the bacte-
rial activities in diverse treatments are completely recovered. 
It has been shown that GSH could eliminate ROS genera-
tion and stabilize AgNPs, and Na
2
S
2
O
3
 could decrease the 
bioavailability of Ag+ by binding with free dissolved Ag+, 
thus reducing the biological activities of the ionic silver.31 
The protection of E. coli by both GSH and Na
2
S
2
O
3
 observed 
earlier suggested that the compromised bacterial growth 
with AgNP treatments could be dominantly regulated by 
the oxidation process of AgNPs concomitant with silver ion 
release and ROS generation.
As the positive control, the effects of silver ions were 
also tested regarding the antibacterial activities against 
Figure 2 The surface ligand regulates silver ion release from agNPs in both concentration- and incubation time-dependent manners.
Notes: The incubation lasted for (A) 6 h and (B) 24 h. *P,0.05 versus the blank control.
Abbreviations: agNPs, silver nanoparticles; cit, citrate; MPa, mercaptopropionic acid; Mha, mercaptohexanoic acid; MPs, mercaptopropionic sulfonic acid.
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E. coli. The results in Figure 3D show that silver ions 
can induce significant bacterial growth inhibition in a 
concentration-dependent manner within the range of 
50–1,000 ng/mL. When compared to AgNPs, silver ions 
had relatively higher toxicities to E. coli, which was consis-
tent with the findings reported previously.7 Similarly, both 
reagents, GSH and Na
2
S
2
O
3
, could completely recover the 
suppressed bacterial viabilities of E. coli induced by silver 
ion exposure, which was similar to the results obtained from 
AgNP exposure experiments. Therefore, it was suggested 
that AgNP-induced bacterial toxicity could be regulated by 
silver ion release from the nanosized Ag core.
Nevertheless, when in vitro silver ion release was evalu-
ated, it was found that 6 h incubation of 1–15 μg/mL AgNPs 
released low levels of silver ions (,20 ng/mL, Figure 2A). 
However, 1–15 μg/mL AgNPs significantly inhibited the 
bacterial activity, as shown in Figure 3A (bacterial toxicity: 
56.5%–95.5% for Cit@AgNPs, 32.4%–95.4% for MPS@
AgNPs, 0.8%–47.4% for MPA@AgNPs, and 0–22.8% for 
MHA@AgNPs), while 20 ng/mL silver ions hardly caused 
any effects (bacterial viability: ~100%, Figure 3D). This 
indicated that the released silver ions in medium might influ-
ence but not dominate AgNP-induced toxicities to E. coli. 
Accordingly, the effects of the extracellular ROS generation 
from the in vitro dissolution of AgNPs were also limited. The 
particle-specific effects could be the predominant mediator in 
AgNP exposure-induced bacterial growth inhibition, rather 
than the negligible effects from the released ionic silver or 
extracellular ROS generated in vitro. It was well known 
that AgNPs might cause cytotoxicity by a Trojan-horse-type 
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Figure 3 The viabilities of E. coli after 6-h exposures of different agNPs.
Notes: (A) agNP treatment alone, (B) The coexposure of agNPs and 1 mM gsh, (C) The coexposure of agNPs and 0.1 mM Na2s2O3, and (D) The exposure of ag
+ in the 
absence or presence of 1 mM gsh or 0.1 mM Na2s2O3. 
aDenotes significant difference between each AgNP exposure group and the negative control (P,0.05). bDenotes 
significant difference between each AgNP (1 μg/ml) plus gsh or Na2s2O3 coexposure group and 1 μg/ml agNP exposure alone (P,0.05). cDenotes significant difference 
between each agNP (5 μg/ml) plus gsh or Na2s2O3 coexposure group and 5 μg/ml agNP exposure alone (P,0.05). dDenotes significant difference between each AgNP 
(15 μg/ml) plus gsh or Na2s2O3 coexposure group and 15 μg/ml agNP exposure alone (P,0.05).
Abbreviations: E. coli, Escherichia coli; agNP, silver nanoparticle; cit, citrate; gsh, glutathione; MPa, mercaptopropionic acid; Mha, mercaptohexanoic acid; MPs, mercapto-
propionic sulfonic acid.
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mechanism, which explained how AgNPs facilitated the 
release of free toxic silver ions in cells, where the particles 
entered and were then ionized.32–34 Accordingly, intracellular 
silver ion release greatly contributed to the antibacterial 
activities of AgNPs. The surface ligand might also regulate 
this process in the similar way to what happened in vitro, 
thus explaining the toxicity order of the four tested AgNPs 
described earlier. In addition, the intracellular oxidative inter-
mediates (H
2
O
2
, etc.) and acidic condition of the organelle 
(lysosome, etc.) might facilitate the oxidation of the silver 
core,32 potentially inducing the generation of more silver ions 
and ROS, which could trigger the corresponding biological 
effects, such as antibacterial activities. With regard to the 
quantification for the percentage of particulate effect, this is 
still challenging due to the complexity of the antibacterial 
mode of AgNPs, and the hot debate on this question continues 
in the related toxicological studies.
cit@agNPs perturb the bacterial 
respiratory chain through binding with 
the bacterial membrane, thus increasing 
intracellular rOs generation
The cellular uptake of AgNPs might provide the substantial 
basis for their biological effects occurring in vivo. Using 
Cit@AgNPs as the representative AgNPs, the distribution 
of Ag in E. coli was studied after 6 h exposure. As shown 
in Figure 4A (left panel), the total Ag levels were similar 
(~120 ng/107 cfu) in E. coli samples treated with 15 μg/mL 
Cit@AgNPs or 0.5 μg/mL Ag+, showing the relatively 
higher biouptake efficiency of silver in Ag+ exposure groups 
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Figure 4 silver ions perturb bacterial respiratory chain, inducing intracellular rOs generation.
Notes: (A) Total ag uptake in E. coli (left panel) and its distribution (right panel); (B) alteration of NaD+/NaDh ratio in E. coli with different treatments as indicated, *P,0.05 
versus the negative control; and (C) the intracellular rOs generation. The concentrations of cit@agNPs, agNO3, gsh, and Na2s2O3 were 15 μg/ml, 0.5 μg/ml, 1.0 mM, 
and 0.1 mM, respectively, *P,0.05 versus the negative control. The exposure lasted for 6 h.
Abbreviations: agNPs, silver nanoparticles; gsh, glutathione; rOs, reactive oxygen species; E. coli, Escherichia coli; cit, citrate; MPa, mercaptopropionic acid; Mha, 
mercaptohexanoic acid; MPs, mercaptopropionic sulfonic acid.
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when compared to Cit@AgNP-treated ones. As the silver 
ion release ratio of 15 μg/mL Cit@AgNPs was less than 
0.02 μg/mL in the medium after 6 h incubation, particulate 
Ag greatly contributed to the silver biouptake in Cit@AgNP-
treated bacteria. Regarding silver distribution, cytoplasmic 
Ag levels were a little bit higher than membrane Ag levels, 
providing the evidence that the extracellular silver either in 
particulate or in ionic forms could bind with the membrane 
and enter into the bacterial bodies. The internalization of 
Ag enabled the biological effects that might happen on the 
membrane or in cytoplasm through a Trojan-horse-type 
mechanism for Cit@AgNPs.
It was well known that there were abundant biological 
enzymes in the bacterial membrane, for example, dehy-
drogenase, oxidative phosphorylation enzyme, and respi-
ratory chain enzymes.18,35 Therefore, the membrane was 
an important location for energy transfer. More specifi-
cally, the respiratory chain in the bacterial membrane was 
in charge of electron and energy transfer, in which, the 
reductive coenzyme of NADH was converted into oxidative 
coenzyme of NAD+, and O
2
 was reduced to H
2
O by gaining 
the electron, and the energy was released for the subsequent 
ATP synthesis in the biological system.35 The occurrence 
of membrane silver might pose high risks for the disruption 
of the respiratory chain, which led to intracellular NADH 
consumption and ROS accumulation.36,37 The evaluation 
for the respiratory chain of E. coli (Figure 4B) shows that 
NAD+/NADH ratios are significantly increased by both Cit@
AgNPs (0.57) and Ag+ treatments (0.62) comparing to the 
control (0.48), indicating the imbalance of the key elements 
in the respiratory chain. The addition of GSH or Na
2
S
2
O
3
 
efficiently erased the increase in NAD+/NADH ratio induced 
by Cit@AgNP exposure. This result was consistent with the 
finding from the bacterial viability assay. As the internalized 
AgNPs might exert hazardous biological effects through a 
Trojan-horse-type mechanism, the released Ag+ could bind/
interact with the essential enzymes on membrane, interrupt 
the electron transfer, generate excessive ROS, and induce 
oxidative stress in E. coli. Therefore, the elimination of 
intracellular ROS and free Ag+ by the reagents, GSH and 
Na
2
S
2
O
3
, blocked the abnormal effects, such as dysfunction 
of the respiratory chain, induced by AgNPs.
As mentioned earlier, AgNP exposure might affect the 
bacterial respiratory chain, potentially causing the imbal-
ance of oxidative–antioxidative system in vivo. The oxidative 
stress was usually triggered by excessive ROS generation 
in cells due to the collapse of the antioxidation system.38 
The intracellular ROS generation was thus evaluated based 
on DCFH-DA assay. The result in Figure 4C shows that, 
similar to Ag+, Cit@AgNP stimulation significantly elevates 
intracellular ROS level, showing the potential oxidative 
stress in the treated E. coli. The cotreatment with reductase 
GSH and Na
2
S
2
O
3
 decreased ROS elevation induced by 
Cit@AgNPs, thus providing efficient protection on the 
bacteria from the subsequent hazardous impacts. It was 
widely reported that AgNP-induced biological effects or 
toxicities were mainly involved with silver ion release or 
intracellular ROS generation,7,11,39 although some studies 
emphasized that AgNPs could efficiently induce oxidative 
stress through excessive ROS production, which was distinct 
from silver ions.17 The results obtained herein revealed the 
concurrence of Ag+ and ROS in AgNP-exposed bacterial 
system, showing the complexity of the antibacterial effects 
induced by AgNPs.
cit@agNP exposure induces oxidative 
damage in E. coli
Oxidative stress induced by intracellular excessive ROS 
generation might pose high risks for the occurrence of 
oxidative damage, thus causing the structural lesions to the 
essential biomacromolecules, such as lipids and DNA. The 
peroxidation of lipid by active free oxidative radicals could 
produce oxidized products of aldehydes, such as MDA and 
4-hydroxyl nonenal (4-NHE), resulting in the loss of cell 
membrane integrity and even damage on cell structure.22,40 
MDA, as a common biomarker, was quantitatively measured 
in E. coli treated with Cit@AgNPs and Ag+ to evaluate the 
potential lipid peroxidation. The results in Figure 5A show 
that Cit@AgNPs and Ag+ treatments slightly increase MDA 
levels in E. coli, indicating the existence of lipid peroxida-
tion due to oxidative damage. Similar to the findings from 
bacterial activity, NAD+/NADH ratio, and ROS assays, the 
protection effect was observed in the coexposure groups of 
Cit@AgNPs plus GSH and Cit@AgNPs plus Na
2
S
2
O
3
, which 
further confirmed that Ag+ release and ROS generation played 
important roles in the mediation of Cit@AgNP-induced 
oxidative damage in E. coli.
Morphological observation using scanning electron 
microscopy might provide direct evidence on the surface 
changes in the organisms. Figure 5B shows that the control 
E. coli is in rod-like shape with the longitudinal diameter 
of ~2 μm. The bacterial surface was smooth and intact. The 
treatments of Cit@AgNPs and Ag+ caused cell collapse 
of E. coli structure, which was characterized by the rough 
surfaces and even breakdown in some bacterial bodies 
(Figure 5C and D). The coincubation of GSH and Na
2
S
2
O
3
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efficiently blocked the morphological damages caused by 
Cit@AgNP exposure, and the bacterial bodies were as intact 
as the controls. This finding was consistent with the results of 
MDA assay and the protection effects of these two reagents 
observed earlier.
The imbalance of oxidation–antioxidation system due 
to intracellular excessive ROS generation might also lead 
to  deleterious effects, such as the alterations of DNA 
structure.41,42 The oxidative modification on certain sites 
of DNA could form representative products. For example, 
hydroxylation on the eighth carbon atom of guanine moi-
ety produced 8-oxo-dG, which was commonly used as 
a sensitive biomarker for DNA oxidative damage. The 
analysis based on LC-MS/MS showed that no detectable 
levels of 8-oxo-dG (,2 nM) were found in E. coli samples 
with diverse treatments (Figure 5G), revealing that, in 
contrast to lipid peroxidation, no DNA oxidative damage 
occurred upon AgNP or Ag+ stimulations.
In summary, the coating ligands of AgNPs regulated 
Ag+ release in vitro and in vivo. By binding with or entering 
into the plasma membrane, AgNPs disturbed the respiratory 
chain in E. coli and caused oxidative stress through a Trojan-
horse-type mechanism. The corresponding deleterious 
effects, including lipid peroxidation, loss in the integrity of 
plasma membrane, and bacterial growth inhibition, could be 
efficiently attenuated by the coexposure of GSH or Na
2
S
2
O
3
, 
confirming the critical roles of ROS concomitant with the 
released Ag+ in antibacterial activities of AgNPs. The overall 
proposed process is sketched in Scheme 1.
Conclusion
In this study, ligand-dependent Ag+ release was found based 
on the comparison of four 10 nm-sized AgNPs coated with 
Cit, MPA, MHA, and MPS, respectively. These ligands 
possess different coordination atoms, carbon chain lengths, 
and terminal groups. The particulate Ag coated with citrate 
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Figure 5 Oxidative damage and morphological changes in E. coli stimulated by cit@agNPs.
Notes: (A) MDa production. scanning electron microscopic images of E. coli samples from the control (B), cit@agNPs (C), ag+ (D), cit@agNPs plus 1 mM gsh (E), and 
cit@agNPs plus 0.1 mM Na2s2O3 (F). (G) 8-oxo-dg generation in E. coli with different treatments as indicated. The concentrations of cit@agNPs and agNO3 were 15 and 
0.5 μg/ml, respectively. The exposure lasted for 6 h.
Abbreviations: 8-oxo-dg, 8-oxoguanine; agNPs, silver nanoparticles; E. coli, Escherichia coli; gsh, glutathione; MDa, malonyldialdehyde; cit, citrate; MPa, mercaptopropionic 
acid; Mha, mercaptohexanoic acid; MPs, mercaptopropionic sulfonic acid.
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had the highest Ag+ release ratio and the strongest antibac-
terial activities against E. coli due to its short carbon chain 
and weak binding atom of oxygen, when compared to the 
other three tested AgNPs. A Trojan-horse-type mechanism 
was proposed as AgNP-induced toxicities could not be fully 
explained by the in vitro Ag+ release. Using Cit@AgNPs as 
the representative, AgNPs were found to perturb the bacte-
rial respiratory chain through binding with the bacterial 
membrane, thus raising intracellular ROS generation and 
the corresponding lipid peroxidation. The findings herein 
provided new insights into roles of ligands in regulating anti-
bacterial properties of nanosilver and the underlying molecu-
lar mechanism. The optimization of the surface ligand, such 
as coordination atom, carbon chain, and terminal group, is 
a very promising strategy in nanoparticle manufacture for 
multiple commercial application purposes.
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Figure S1 growth curve of E. coli Mg1655 in lB growth medium.
Abbreviations: E. coli, Escherichia coli; lB, luria–Bertani; OD600, optical density at 600 nm.
Figure S2 (Continued)
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Figure S2 XPs spectrum of agNPs with four surface ligands, including cit, MPa, Mha, and MPs.
Abbreviations: agNPs, silver nanoparticles; cit, citrate; MPa, mercaptopropionic acid; Mha, mercaptohexanoic acid; MPs, mercaptopropionic sulfonic acid; XPs, X-ray 
photoelectron spectroscopy.
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